Significant Achievements: Successfully Cultivated Human Heart in Pigs, Bringing New Hope for Organ Transplantation
Release time:
2025-06-19
Recently, the world's top - tier academic journal Nature featured a major research achievement by Chinese scientists on its front - page headlines. For the first time, a heart containing human cells was cultivated in a pig embryo, and this heart could beat autonomously and survived for 21 days. This groundbreaking progress offers a brand - new solution to the global shortage of organ transplants and marks a new stage in the development of xenogeneic organ cultivation technology.
Breakthrough: Human Heart Grown in Pig Embryo
This research was led by the team of Researcher Lai Liangxue from the Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences. The research team adopted the human - animal chimeric technology. They used gene editing to knock out two key genes related to heart development in the pig embryo. Then, at the morula stage (when the embryo consists of about 32 cells), genetically enhanced human stem cells were injected. These stem cells had been specially modified to have stronger survival and proliferation abilities.
The research team confirmed that the pig embryo carrying human cardiac progenitor cells, constructed through advanced technological means, could develop smoothly in the surrogate sow for up to 21 days. Significantly, during this period, the heart tissue in the embryo had grown to a size comparable to that of a human embryo's heart at the same stage (about the size of a fingertip), and regular autonomous beating was observed.
Core Technology: The Exquisite Synergy of Gene Editing and Stem Cell Engineering
The core of this research lies in the cutting - edge "human - animal chimeric" cultivation strategy, with a rigorous and precise technical roadmap:
Targeted gene knockout: The research team first used gene - editing technologies such as CRISPR - Cas9 to precisely knock out two specific genes crucial for the normal development of the pig embryo's heart, creating space for the "take - over" of human cells.
Enhanced modification of human stem cells: The human stem cells injected into the embryo were not in their original state. Through gene reprogramming technology, the team introduced specific genes that could prevent cell death and promote cell growth into these stem cells, significantly enhancing their survival ability, adaptability, and competitiveness in the xenogeneic micro - environment of the pig embryo.
Precise spatio - temporal injection and in - vivo cultivation: At the early morula stage of the pig embryo's development, researchers precisely injected a small amount of the above - mentioned enhanced human stem cells. Subsequently, these chimeric embryos were transplanted into surrogate sows.
Existing Challenges and Future Directions: Survival Period and Cell Purity Are Key
Despite the remarkable achievements, the research team also clearly pointed out the severe challenges faced by the current technology:
21 - day survival limit: All chimeric embryos in the experiments stopped growing and died after developing for 21 days. Lai Liangxue analyzed that the presence of human cells in the heart tissue might have interfered with the original functional coordination or development program of the pig embryo's heart, resulting in the inability of the embryo to continue surviving.
Proportion of human cells and risk of immune rejection: The specific proportion of human cells in the cultivated heart tissue has not been announced in this report. Referring to the team's previous research on cultivating early human kidneys (mesonephros) in pigs (where the proportion of human cells reached 40% - 60%), there is still a considerable distance from the goal of "fully human - sourced" organs.
Scientific Significance and Prospects
Pigs are regarded as ideal donor candidates for xenogeneic organ transplantation and chimeric organ cultivation due to the high similarity of their organs in size, anatomical structure, and physiological function to those of humans. In recent years, preliminary explorations of short - term human transplantation of gene - edited pig kidneys and hearts have been successfully carried out. The human - animal chimeric technology aims to cultivate organs in animals that are fully compatible with human recipients, and it is considered one of the long - term strategies to solve the global problem of extreme organ shortage.
The team led by Lai Liangxue had previously successfully cultivated early human kidney tissue in pig embryos and maintained its survival for up to one month. This time, achieving the breakthrough of a beating function in the more complex heart tissue marks another major leap forward in this technological route.
Conclusion
This groundbreaking research brings revolutionary hope for the large - scale cultivation of transplantable human organs using large mammals. Although multiple obstacles still need to be overcome before clinical application, it undoubtedly lights a crucial scientific beacon for millions of desperate patients on the global organ waiting list. The grand vision of humans cultivating transplantable organs with the help of animals is gradually moving from basic laboratory research towards the realm of reality.
Latest developments
Over the two days, the symposium was not only a collision of ideas but also seeds sown to advance social progress in life culture. The Shandong Yinfeng Life Science Public Welfare Foundation will continue to use technology as wings and culture as roots, collaborating with all sectors of society to enhance the quality of life for the Chinese people and build a human-centered life care system.
According to recent announcements by the Jinan Municipal Bureau of Science and Technology, 11 outstanding achievements from Jinan have been included in the 2025 "Shandong Outstanding Achievements Report" project. Among them is the globally first-of-its-kind ovarian tissue dual-activation technology developed by Shandong Silver Med Life Science Research Institute (Jinan).
Recently, Frigid Zone Medicine, an authoritative international journal in the field of cryomedicine, published an important review titled "Advances in the Detection Methods for Assessing the Viability of Cryopreserved Samples". Written by the team of Yinfeng Cryomedical Research Center, the article systematically reviews and analyzes various detection techniques currently used to evaluate the viability of cryopreserved cells, tissues, and organs. It also proposes key directions from the perspectives of methodological integration and future instrument development, offering crucial theoretical support and practical guidance for the long - term cryopreservation of complex tissues and organs.
Recently, the "Novel Technology for Ultra-Low Temperature Cryopreservation, Activation, and Transplantation of Human Ovarian Tissue," developed through a collaborative effort between Shandong Yinfeng Life Science Research Institute and Beijing University of Chinese Medicine Shenzhen Hospital, has been awarded the 2025 Shandong Refrigeration and Air Conditioning Science and Technology Award. This groundbreaking technology pioneers a new pathway for female fertility preservation, marking a significant leap in China’s interdisciplinary advancements in reproductive medicine and cryobiology.
On May 19, a delegation from the Chinese Training Workshop for Government Officials of Developing Countries visited the exhibition hall of Yinfeng Biological Group's Cryomedicine Research Center. Government officials from multiple countries gained in-depth insights into Yinfeng’s innovative achievements in cryobiomedicine, cell storage, genetic technology, and other fields. They engaged in discussions with the delegation on technology transfer and international cooperation, contributing to the building of a global community with a shared future for humanity.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155507
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
